| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.078 | 0.008 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |